# GO_biological_process_0015

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **A** — secondary metabolite biosynthetic process

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSPHISPSKDTPSQRLPIPLSLPTHLGLLAKAYGVPPASILQLAWGLVLRCYFTTSSSRWGTIDMAHEYKEKKNLPIRCEVLELDDTRSIGWILQNWNDPSVHRHLPAEEDTSNVPVSAGSIVILTEDAKDLEVLRDFELTAEWIICFSTSTEKPLLRLSWRPDVIHSELASHLAQLLERALDTTFLSPDIPLSQINLFSILDHQKLLQWNHQYPQSVNRLVHEMFEDMVAARPQATAVAAWDGEVTYQQLDRLSTRLAIKLQTIDLQPESIVALCFEKSVWAIVAMLGVLRAGGAFLHIDPKHPTARQQAMISTTAARIILCSEQTRDTVSRFDSESLSLVVDRKMFAQEPDHKQVALPSPNNLGPRNAAYIVCTSGSTGLPKAIVVEHVSLCTSVTAQAEAMAVGGESRILQYAAYTFDVSVGDVFTALTHGACVCIPSDWERTQDLVGAINRLDVNQACLTSTVASFLTPMNVPKLQKLTLGGEPASKQCIDLWSGKVALKNVYGPAECTVWCVIQKNASSEIPASNIGRGIGARTWIVHPENHNQLMPIGAVGELLIEGPLVARGYLNDAERTTAVFLERAPSWLATFGPLPPQTRFYKTGDLARFEQNGTLFFEGRKDTQVKLRGQRIELGEIEYQIQQACNPVPPLAVELIETKDLQAPLLGAFITWTGGLEISLDQSAVPNGLGPDLDARSHFNELVSRIQANIDRTLPPYMMPGLYIPVQKLPLSTSGKLDRKVLRQYCTQHTRSFLTASEAESSDVIADDATKDDVALHEIVNPGEITLAQLWAHALGRRMESINAKDNFLSLGGDSLAAMRLVNLAARDAQVTLTVANIFESPVLADQARLLRPLSKTKSLAPFELMTRGEASIEDIVGFAAQQCRLLPAQIEDVYPCTPLQEEMMRDSLSNDRTQMGQEVVQISEELDLVRYQVACASVYRRFPILRTRFIEHSGRLVQVVVREDLCWKQPTSLAEYKALDSRERPALGKPLTRWALTSDGTHFILSLHHAMFDGITLGQIQGAIYAVYQCIPLPPPSVSFATFLAHLDDQNAPLSQESQRFWQSYLCPSASLDASITPETQKIDRPRASCGTQRLVQFTSGEVSALQRHGLTEATLVRGAWACTLARHQQKPHASAFSDVIFGTMLTGRNFHLPGVDMLAAPSLTHVPIRIRIDEGDLNGHSARALLARVQADATAMIPYEHDGMNRIRSIEVQTRAVFNRIRTLLVIQPIPEGLTSVSTSPFPGSIVSGPRVEAKEMGHFHWYGLLVECTLLPTKGFFVRVSYDNKMFGTEQVESLLDDYSTTLHTLANGLMDTDIPASLHV

[Multiple Choices]
A. secondary metabolite biosynthetic process
B. negative regulation of oxidative phosphorylation
C. mechanosensory behavior
D. exocrine pancreas development
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the 1325-aa UniProt entry for a nonribosomal peptide synthetase in the lanomycin biosynthetic cluster. The entry assigns secondary metabolite biosynthetic process, though that GO annotation is computational (IEA:TreeGrafter); its function and pathway statements cite a publication.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C8](#evidence-c8), [H3](#evidence-h3), [H6](#evidence-h6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The long, multidomain sequence has features consistent with a nonribosomal peptide synthetase. Such enzymes assemble peptide natural products, supporting secondary-metabolite biosynthesis over the choices about animal behavior, oxidative phosphorylation regulation, or pancreas development.


**Missing item-specific fact**

> Identifying the particular product as lanomycin would require protein-specific information, but that detail is not needed to distinguish the broad biological process in choice A.


**Reason**

> The sequence provides a defensible enzyme-family inference that meaningfully separates choice A from the unrelated alternatives; selection need not rely on recognizing the exact protein or recalling its database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed choices, secondary metabolite biosynthesis is the clear fit for a nonribosomal peptide synthetase.


### Important caveats

- The specific accession and database annotations are reviewer-only evidence, not information supplied to the evaluated model.
- The GO annotation cited here is computational; the cited protein-function and pathway annotation should not be mistaken for a direct experimental validation of every mechanistic detail.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long, multidomain sequence has features consistent with a nonribosomal peptide synthetase. Such enzymes assemble peptide natural products, supporting secondary-metabolite biosynthesis over the choices about animal behavior, oxidative phosphorylation regulation, or pancreas development.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Identifying the particular product as lanomycin would require protein-specific information, but that detail is not needed to distinguish the broad biological process in choice A.",
    "reason": "The sequence provides a defensible enzyme-family inference that meaningfully separates choice A from the unrelated alternatives; selection need not rely on recognizing the exact protein or recalling its database entry."
  },
  "case_id": "GO_biological_process_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C8",
      "H3",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the 1325-aa UniProt entry for a nonribosomal peptide synthetase in the lanomycin biosynthetic cluster. The entry assigns secondary metabolite biosynthetic process, though that GO annotation is computational (IEA:TreeGrafter); its function and pathway statements cite a publication."
  },
  "important_caveats": [
    "The specific accession and database annotations are reviewer-only evidence, not information supplied to the evaluated model.",
    "The GO annotation cited here is computational; the cited protein-function and pathway annotation should not be mistaken for a direct experimental validation of every mechanistic detail."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, secondary metabolite biosynthesis is the clear fit for a nonribosomal peptide synthetase."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the 1325-aa UniProt entry for a nonribosomal peptide synthetase in the lanomycin biosynthetic cluster. The entry assigns secondary metabolite biosynthetic process, though that GO annotation is computational (IEA:TreeGrafter); its function and pathway statements cite a publication.",
    "evidence_ids": ["C1", "C4", "C5", "C8", "H3", "H6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The long, multidomain sequence has features consistent with a nonribosomal peptide synthetase. Such enzymes assemble peptide natural products, supporting secondary-metabolite biosynthesis over the choices about animal behavior, oxidative phosphorylation regulation, or pancreas development.",
    "missing_item_specific_fact": "Identifying the particular product as lanomycin would require protein-specific information, but that detail is not needed to distinguish the broad biological process in choice A.",
    "reason": "The sequence provides a defensible enzyme-family inference that meaningfully separates choice A from the unrelated alternatives; selection need not rely on recognizing the exact protein or recalling its database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, secondary metabolite biosynthesis is the clear fit for a nonribosomal peptide synthetase."
  },
  "important_caveats": [
    "The specific accession and database annotations are reviewer-only evidence, not information supplied to the evaluated model.",
    "The GO annotation cited here is computational; the cited protein-function and pathway annotation should not be mistaken for a direct experimental validation of every mechanistic detail."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The protein (UniProt P0DXV4, LAN2_PYRDE) is experimentally characterized (PubMed:33857369) as a Nonribosomal peptide synthetase (NRPS) and lanomycin biosynthesis cluster protein 1 in Pyrenophora dematioidea. Lanomycin is a tetrahydropyranyl antifungal agent—a classic secondary metabolite. GO:0044550 (secondary metabolite biosynthetic process) is annotated to this entry (IEA:TreeGrafter), and the underlying functional annotation is supported by experimental evidence (ECO:0000269|PubMed:33857369). NRPS enzymes are textbook secondary metabolite biosynthetic enzymes, and the pathway annotation 'Antifungal biosynthesis' confirms the secondary metabolite context.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C8](#evidence-c8), [H3](#evidence-h3), [H4](#evidence-h4), [H6](#evidence-h6), [GO3](#evidence-go3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1325-aa sequence contains recognizable NRPS domain signatures: the 'SGSTG' motif (adenylation/A-domain signature, visible in 'AAYIVCTSGSTGLPKAIVVEHVSL'), the 'HH' motif of A-domains, and the overall multi-domain architecture characteristic of NRPS enzymes. General biochemistry knowledge establishes that NRPS enzymes assemble peptide-based natural products (secondary metabolites) via iterative adenylation, condensation, and thiolation. This directly maps to 'secondary metabolite biosynthetic process.' The distractors are clearly excluded: no mitochondrial targeting or respiratory-chain motifs (B), no mechanosensory ion-channel architecture or animal context (C), and no developmental signaling or digestive-enzyme precursor features in a fungal protein (D).


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Identifying NRPS domain architecture from sequence (A-domain SGSTG motif, C-domain, T-domain patterns) and knowing that NRPS enzymes produce secondary metabolites are standard biochemistry knowledge, not a protein-specific annotation lookup. The biological reasoning chain—sequence signatures → NRPS → secondary metabolite biosynthesis—is generalizable and does not require memorizing the specific UniProt entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The other three options (negative regulation of oxidative phosphorylation, mechanosensory behavior, exocrine pancreas development) are biologically incompatible with a fungal NRPS. No ambiguity exists among the choices.


### Important caveats

- The GO:0044550 annotation carries evidence code IEA:TreeGrafter (computational transfer), but the underlying function (lanomycin biosynthesis) is experimentally supported by PubMed:33857369.
- The protein is from Pyrenophora dematioidea, a non-model fungus; domain recognition from raw sequence requires specialized NRPS biochemistry knowledge.
- The UniProt entry was first released in 2025 (Swiss-Prot), so the annotation is relatively recent; the author's source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1325-aa sequence contains recognizable NRPS domain signatures: the 'SGSTG' motif (adenylation/A-domain signature, visible in 'AAYIVCTSGSTGLPKAIVVEHVSL'), the 'HH' motif of A-domains, and the overall multi-domain architecture characteristic of NRPS enzymes. General biochemistry knowledge establishes that NRPS enzymes assemble peptide-based natural products (secondary metabolites) via iterative adenylation, condensation, and thiolation. This directly maps to 'secondary metabolite biosynthetic process.' The distractors are clearly excluded: no mitochondrial targeting or respiratory-chain motifs (B), no mechanosensory ion-channel architecture or animal context (C), and no developmental signaling or digestive-enzyme precursor features in a fungal protein (D).",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Identifying NRPS domain architecture from sequence (A-domain SGSTG motif, C-domain, T-domain patterns) and knowing that NRPS enzymes produce secondary metabolites are standard biochemistry knowledge, not a protein-specific annotation lookup. The biological reasoning chain—sequence signatures → NRPS → secondary metabolite biosynthesis—is generalizable and does not require memorizing the specific UniProt entry."
  },
  "case_id": "GO_biological_process_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C8",
      "H3",
      "H4",
      "H6",
      "GO3"
    ],
    "judgment": "supported",
    "reason": "The protein (UniProt P0DXV4, LAN2_PYRDE) is experimentally characterized (PubMed:33857369) as a Nonribosomal peptide synthetase (NRPS) and lanomycin biosynthesis cluster protein 1 in Pyrenophora dematioidea. Lanomycin is a tetrahydropyranyl antifungal agent—a classic secondary metabolite. GO:0044550 (secondary metabolite biosynthetic process) is annotated to this entry (IEA:TreeGrafter), and the underlying functional annotation is supported by experimental evidence (ECO:0000269|PubMed:33857369). NRPS enzymes are textbook secondary metabolite biosynthetic enzymes, and the pathway annotation 'Antifungal biosynthesis' confirms the secondary metabolite context."
  },
  "important_caveats": [
    "The GO:0044550 annotation carries evidence code IEA:TreeGrafter (computational transfer), but the underlying function (lanomycin biosynthesis) is experimentally supported by PubMed:33857369.",
    "The protein is from Pyrenophora dematioidea, a non-model fungus; domain recognition from raw sequence requires specialized NRPS biochemistry knowledge.",
    "The UniProt entry was first released in 2025 (Swiss-Prot), so the annotation is relatively recent; the author's source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The other three options (negative regulation of oxidative phosphorylation, mechanosensory behavior, exocrine pancreas development) are biologically incompatible with a fungal NRPS. No ambiguity exists among the choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The protein (UniProt P0DXV4, LAN2_PYRDE) is experimentally characterized (PubMed:33857369) as a Nonribosomal peptide synthetase (NRPS) and lanomycin biosynthesis cluster protein 1 in Pyrenophora dematioidea. Lanomycin is a tetrahydropyranyl antifungal agent—a classic secondary metabolite. GO:0044550 (secondary metabolite biosynthetic process) is annotated to this entry (IEA:TreeGrafter), and the underlying functional annotation is supported by experimental evidence (ECO:0000269|PubMed:33857369). NRPS enzymes are textbook secondary metabolite biosynthetic enzymes, and the pathway annotation 'Antifungal biosynthesis' confirms the secondary metabolite context.",
    "evidence_ids": ["C4", "C5", "C6", "C8", "H3", "H4", "H6", "GO3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1325-aa sequence contains recognizable NRPS domain signatures: the 'SGSTG' motif (adenylation/A-domain signature, visible in 'AAYIVCTSGSTGLPKAIVVEHVSL'), the 'HH' motif of A-domains, and the overall multi-domain architecture characteristic of NRPS enzymes. General biochemistry knowledge establishes that NRPS enzymes assemble peptide-based natural products (secondary metabolites) via iterative adenylation, condensation, and thiolation. This directly maps to 'secondary metabolite biosynthetic process.' The distractors are clearly excluded: no mitochondrial targeting or respiratory-chain motifs (B), no mechanosensory ion-channel architecture or animal context (C), and no developmental signaling or digestive-enzyme precursor features in a fungal protein (D).",
    "missing_item_specific_fact": "",
    "reason": "Identifying NRPS domain architecture from sequence (A-domain SGSTG motif, C-domain, T-domain patterns) and knowing that NRPS enzymes produce secondary metabolites are standard biochemistry knowledge, not a protein-specific annotation lookup. The biological reasoning chain—sequence signatures → NRPS → secondary metabolite biosynthesis—is generalizable and does not require memorizing the specific UniProt entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The other three options (negative regulation of oxidative phosphorylation, mechanosensory behavior, exocrine pancreas development) are biologically incompatible with a fungal NRPS. No ambiguity exists among the choices."
  },
  "important_caveats": [
    "The GO:0044550 annotation carries evidence code IEA:TreeGrafter (computational transfer), but the underlying function (lanomycin biosynthesis) is experimentally supported by PubMed:33857369.",
    "The protein is from Pyrenophora dematioidea, a non-model fungus; domain recognition from raw sequence requires specialized NRPS biochemistry knowledge.",
    "The UniProt entry was first released in 2025 (Swiss-Prot), so the annotation is relatively recent; the author's source snapshot is unknown."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `P0DXV4` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 4. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:46.025798+00:00.  

```json
"P0DXV4"
```

Source SHA-256: `6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:46.025798+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33857369","source":"PubMed"}],"value":"Lanomycin biosynthesis cluster protein 1"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"33857369","source":"PubMed"}],"value":"6.3.2.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33857369","source":"PubMed"}],"value":"Nonribosomal peptide synthetase"}}}
```

Source SHA-256: `6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:46.025798+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33857369","source":"PubMed"},{"evidenceCode":"ECO:0000305"}],"value":"Nonribosomal peptide synthetase; part of the gene cluster that mediates the biosynthesis of the tetrahydropyranyl antifungal agent lanomycin that acts as an inhibitor of CYP51 and blocks the ergosterol biosynthesis (PubMed:33857369). The biosynthesis probably begins with the formation of an hexaketide, followed by methionine mediated alkylation of C-2 and C-6, and methylation of the reduced C-3 oxygen, pyran forming reductive ring closure, oxygenation of C-4, beta-keto reduction, enoyl reduction and dehydration of the remaining oxygens, and finally, acylation with glycine to complete the biosynthesis (Probable)"}]}
```

Source SHA-256: `6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:46.025798+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"33857369","source":"PubMed"}],"value":"Antifungal biosynthesis"}]}
```

Source SHA-256: `6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd`.

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV4.json)  
**Locator:** `/uniProtKBCrossReferences/7`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:46.025798+00:00.  

```json
{"database":"GO","id":"GO:0044550","properties":[{"key":"GoTerm","value":"P:secondary metabolite biosynthetic process"},{"key":"GoEvidenceType","value":"IEA:TreeGrafter"}]}
```

Source SHA-256: `6306f5ce87df5ee04db986988c948755e8b2c4fe4ace8282933e84b394cf62fd`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)  
**Locator:** `lines 24-33`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:48.541613+00:00.  

```text
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of the tetrahydropyranyl antifungal
CC       agent lanomycin that acts as an inhibitor of CYP51 and blocks the
CC       ergosterol biosynthesis (PubMed:33857369). The biosynthesis probably
CC       begins with the formation of an hexaketide, followed by methionine
CC       mediated alkylation of C-2 and C-6, and methylation of the reduced C-3
CC       oxygen, pyran forming reductive ring closure, oxygenation of C-4, beta-
CC       keto reduction, enoyl reduction and dehydration of the remaining
CC       oxygens, and finally, acylation with glycine to complete the
CC       biosynthesis (Probable). {ECO:0000269|PubMed:33857369, ECO:0000305}.
```

Source SHA-256: `ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)  
**Locator:** `lines 37-37`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:48.541613+00:00.  

```text
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:33857369}.
```

Source SHA-256: `ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV4?format=txt&versions=4)  
**Locator:** `lines 60-60`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:48.541613+00:00.  

```text
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:TreeGrafter.
```

Source SHA-256: `ba16325a29b0d20c33cbeceb3d33ee2d578da70c3cbda9228dab9fae89b8c8fd`.

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 258299-258308`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0044550
name: secondary metabolite biosynthetic process
namespace: biological_process
def: "The chemical reactions and pathways resulting in the formation of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon." [GOC:jl]
subset: goslim_prokaryote
synonym: "secondary metabolite biosynthesis" EXACT []
is_a: GO:0009058 ! biosynthetic process
is_a: GO:0019748 ! secondary metabolic process

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 15. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
